Related Experiment Video
Updated: Mar 12, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inflammatory biomarkers of coronary heart disease
Hongyu Li1, Kai Sun2, Ruiping Zhao3
1Department of Cardiology, Baotou Central Hospital, Baotou, China.
Insights
Coronary heart disease involves artery plaque buildup and inflammation. This review highlights key inflammatory biomarkers like C-reactive protein (CRP) and myeloperoxidase (MPO) in its development.
Area of Science:
- Cardiovascular Science
- Immunology
- Biochemistry
Background:
- Coronary heart disease (CHD) is a condition marked by arterial plaque accumulation and inflammation.
- Cardiovascular risk factors such as obesity, diabetes, and hypertension worsen CHD.
- Inflammation is a key component in the development of CHD.
Purpose of the Study:
- To review the role of traditional inflammatory biomarkers in CHD pathogenesis.
- To emphasize the significance of specific biomarkers in understanding CHD development.
Main Methods:
- Literature review of studies on inflammatory biomarkers and CHD.
- Analysis of the role of interleukin-6, C-reactive protein (CRP), complement, CD40, and myeloperoxidase (MPO).
Main Results:
- Interleukin-6, CRP, complement, CD40, and MPO are critical in CHD pathogenesis.
- These biomarkers are integral to the inflammatory processes underlying plaque formation.
- Understanding these markers aids in comprehending CHD development.
Conclusions:
- Traditional inflammatory biomarkers play a crucial role in the pathogenesis of coronary heart disease.
- Further research into these markers can offer insights into CHD prevention and treatment.
Abstract:
Coronary heart disease (CHD), characterized by inflammation and accumulation of plaques mainly comprised of lipids, calcium and inflammatory cells in the walls of coronary arteries. CHD is exacerbated by specific cardiovascular risk factors, such as obesity, diabetes mellitus, and hypertension. The current review focuses on the critical role of traditional inflammatory biomarkers, including interleukin-6, C-reactive protein (CRP), complement, CD40 and myeloperoxidase (MPO), in the pathogenesis of CHD.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology